The microbial epigenome in metabolic syndrome

Area of Science:

• Microbiology
• Metabolic Disorders
• Epigenetics

Background:

• Gut microbiota composition and function are influenced by diet, lifestyle, medications, and food additives.
• Metabolic syndrome is linked to an altered gut microbiota, contributing to systemic low-grade inflammation.
• Epigenetic patterns are also associated with metabolic syndrome and may be influenced by gut microbial alterations.

Purpose of the Study:

• To review the structural and compositional differences in gut microbiota associated with metabolic syndrome.
• To explore how these microbial differences impact epigenetic patterns.
• To examine the role of aberrant bioactive microbial metabolites in affecting epigenetic modifications and inflammatory pathways in metabolic syndrome.

Main Methods:

• Literature review focusing on studies examining gut microbiota composition in metabolic syndrome.
• Analysis of research on the link between gut microbial metabolites and epigenetic modifications.
• Synthesis of findings related to G-protein coupled receptors and inflammatory pathways affected by microbial metabolites.

Main Results:

• Metabolic syndrome is characterized by specific alterations in gut microbiota composition.
• Aberrant microbial metabolites in metabolic syndrome can influence host epigenetics.
• These metabolites impact key pathways, including G-protein coupled receptors and inflammation.

Conclusions:

• Gut microbiota dysbiosis is a significant factor in metabolic syndrome.
• Microbial metabolites play a crucial role in mediating the effects of gut microbiota on host epigenetics and inflammation in metabolic syndrome.
• Targeting gut microbiota and its metabolites may offer therapeutic strategies for metabolic syndrome.